Drag a card by its title · ⚙ to size, swap or remove

Who

Jasper van Grunsven

EVP, CP and NPPO

Company insider

Files Form 4 as: EVP, CP and NPPO, Vertex Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed: 2
Buys: 0
Sells: 0
Bought: $0
Sold: $0
Companies: 1
Companies where not an officer: 0
First trade: 8 Sep 2026
Last trade: 8 Sep 2026
Last filed: 10 Sep 2026

Companies traded

Where they are an officer

VRTX Vertex PharmaceuticalsOfficer · Biotechnology · last 8 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

Traded	Company	What	Amount
8 Sep 2026filed 10 Sep 2026	VRTX Vertex PharmaceuticalsBiotechnology	SEC FORM 4 Code A	—8,682 at $0.00	filing
8 Sep 2026filed 10 Sep 2026	VRTX Vertex PharmaceuticalsBiotechnology	SEC FORM 4 Code A	—8,682 at $0.00	filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Kristen AmbroseSVP & Chief Accounting Officer · SVP & Chief Accounting Officer at Vertex Pharmaceuticals Inc / Ma, filing Form 4 there in the last year

Bruce I. SachsDirector · Director at Vertex Pharmaceuticals Inc / Ma, filing Form 4 there in the last year

Ourania TatsisEVP, Chief Reg. & Quality Off. · EVP, Chief Reg. & Quality Off. at Vertex Pharmaceuticals Inc / Ma, filing Form 4 there in the last year

Amit SachdevEVP Chief Patient & Ext Af Off · EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc / Ma, filing Form 4 there in the last year

Alan M. GarberDirector · Director at Vertex Pharmaceuticals Inc / Ma, filing Form 4 there in the last year